Coca-Cola topped Wall Street's expectations for earnings and revenue.Food & Beverageread more
Disney can nearly double its earnings by 2024, Morgan Stanley said in a note to clients on Tuesday.Investingread more
Amazon is expected to report its second-quarter earnings on Thursday.Investingread more
Here are the biggest calls on Wall Street on TuesdayInvestingread more
Activist hedge-fund billionaire Paul Singer has taken a 7 percent stake in small American health-care company Mednax and is asking the board of directors to consider a sale of the company.
Singer's hedge fund, Elliott Management, disclosed the new stock acquisition on Thursday in a filing with the Securities and Exchange Commission.
Elliott, which holds at least $34 billion under management, owns a combined $84.9 million in Mednax Common Stock. Of that amount, Elliott International, a Cayman Islands-based subsidiary, owns shares worth $57.7 million at the Nov. 3 closing price of $43.37 apiece.
In the government filing, Elliott argues that shares of Mednax, a Florida health-care company providing subspecialty medical services across the country, are "undervalued." The hedge fund says it seeks to "engage in a constructive dialogue" with regard to "strategic options and operational opportunities to maximize shareholder value."
Among those options, Elliott is asking the Mednax board of directors to consider "without limitation, a sale of the Issuer or certain of its businesses or assets ... as a means of enhancing shareholder value."
Mednax stock jumped more than 11 percent to $51.07 per share on Thursday.